课题基金 / 基金详情

Investigation on the molecular mechanism of NPC1L1-mediated cholesterol uptake

Investigation on the molecular mechanism of NPC1L1-mediated cholesterol uptake
NPC1L1介导胆固醇摄取的分子机制研究
批准号:
18390047
负责人:
ITO Kousei
金额:
$6.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

ITO Kousei的其他基金

相似基金

相关文献

中文摘要
翻译
越来越多的证据表明,Niemann-Pick cl -样1 (NPClL1)对肠道胆固醇吸收至关重要,是一种新型降胆固醇药物ezetimibe的靶点。本项目分离了人NPClL1 cDNA,构建了过表达NPClL1的人Caco-2细胞。NPClL1蛋白主要在肠顶膜上检测到,这反映了NPClL1在肠刷缘膜上的生理表达。研究还表明,胆固醇的转运活性与引入的NPClL1的表达水平呈正相关,依折替米贝以浓度依赖性的方式抑制胆固醇的摄取。此外,由于已经确定胆固醇通过多种转运体和/或受体在质膜上的转移与磷脂的转移有关,我们研究了NPClL1对胆固醇的摄取是否也发生在脂质相关机制中。研究发现,NPClL1的过表达导致胆固醇、磷脂酰胆碱和牛磺胆酸组成的胶束对胆固醇和磷脂酰胆碱的摄取增加,但胆固醇的运输活性水平远高于磷脂酰胆碱的运输活性水平。此外,磷脂酰胆碱的摄取对依折替米比的敏感性远低于胆固醇的摄取。相反,npcll1介导的牛磺胆酸盐摄取很少。还证明了磷脂酰胆碱和牛磺胆酸的吸收和依折替米的敏感性不受胆固醇存在的影响。综上所述,尽管NPClL1具有从胶束中摄取磷脂的有效活性,但胆固醇是NPClL1在胶束组分中较好的底物,依泽替米贝对胆固醇摄取的抑制作用相对有选择性。
英文摘要
Cumulative evidence suggests that Niemann-Pick Cl-like 1 (NPClL1) is essential for intestinal cholesterol absorption and is the target of ezetimibe, a novel cholesterol-lowering drug. In this project, we isolated human NPClL1 cDNA and constructed human NPClL1-overexpressing Caco-2 cells. NPClL1 protein was mainly detected on the apical membrane, which reflects the physiological expression of NPClL1 on the intestinal brush border membrane. It was also shown that the transport activities of cholesterol were positively correlated with the expression level of introduced NPClL1 and ezetimibe inhibited the uptake in a concentration-dependent manner. In addition, since it has also been established that the transfer of cholesterol across the plasma membrane via many kinds of transporters and/or receptors is associated with the transfer of phospholipids, we examined whether the uptake of cholesterol by NPClL1 also takes place in the lipid-associated mechanism. It was found that overexpression of NPClL1 results in an increase in the uptake of both cholesterol and phosphatidylcholine from micelles composed of cholesterol, phosphatidylcholine and taurocholate but that the level of transport activity for cholesterol was much higher than that for phosphatidylcholine. In addition, the uptake of phosphatidylcholine was much less sensitive to ezetimibe than the uptake of cholesterol. In contrast, NPClL1-mediated uptake of taurocholate was minimal. It was also demonstrated that the uptake and ezetimibe-sensitivity of phosphatidylcholine and taurocholate from the micelles were not affected by the presence of cholesterol. Taken together, the results suggested that cholesterol is a preferable substrate of NPClL1 in micellar components and the inhibitory effect of ezetimibe is relatively selective to cholesterol uptake, although NPClL1 has potent activity for uptake of phospholipids from micelles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury.
吲哚美辛诱导的肠道损伤大鼠中 BSP 肝脏转运蛋白的下调。
DOI: --
发表时间: 2007
期刊: Biol. Pharm. Bull. 30 (3)
影响因子: --
作者: [Fujiyama N, Shitara Y, Ito K, Masubuchi Y, Horie T]
通讯作者: Horie T
DOI: 10.1016/j.freeradbiomed.2006.02.015
发表时间: 2006-06
期刊: Free radical biology & medicine
影响因子: 7.4
作者: [Shuichi Sekine;Kousei Ito;T. Horie]
通讯作者: Shuichi Sekine;Kousei Ito;T. Horie
Cholesterol lowering effect of ezetimibe in UDP-glucuronosyl transferase (UGT) 1A deficient (Gunn) rats
依折麦布对 UDP-葡萄糖醛酸转移酶 (UGT) 1A 缺陷 (Gunn) 大鼠的胆固醇降低作用
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Takehito Yamamoto, Kousei Ito, Masashi Honma, Tappei Takada, Hiroshi Suzuki]
通讯作者: Hiroshi Suzuki
Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-dedicient (Gunn) rats
依折麦布对尿苷二磷酸葡萄糖醛酸转移酶 1A 缺陷 (Gunn) 大鼠的降胆固醇作用
DOI: --
发表时间: 2007
期刊: Drug Metab Dispos. 35(9)
影响因子: --
作者: [Yamamoto T, et. al.]
通讯作者: et. al.
共 9 条
    Construction of improved lymphocyte transformation test based on the onset and aggravation mechanism of drug-induced liver injury
    • 批准号:
      25670068
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      ITO Kousei
    • 依托单位:
    Analysis of the molecular mechanism of hepatic GSH decrease during drug induced liver injury.
    • 批准号:
      22790146
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2010
    • 负责人:
      ITO Kousei
    • 依托单位:
    海外基金